Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

PEG-Intron A advances to phase III trials for chronic myelogenous leukemia

Nov. 25, 1998

Novopharm Biotech completes patient enrollment for phase I study of NOVOMAb-G2

Nov. 23, 1998

New U.S. patent provides protection for improved Avicine formulations

Nov. 20, 1998

Vical provides clinical update of Allovectin-7 in treatment of head and neck cancer

Nov. 18, 1998

Study shows Zadaxin plus chemotherapy inhibits cancerous tumors in mice

Nov. 18, 1998

New Maxamine data to be presented at annual symposium

Nov. 18, 1998

Protein Design Labs grants patent license to Genentech

Nov. 16, 1998

Axis Genetics and Biomira collaborate on the development of a cancer vaccine

Nov. 16, 1998

AltaRex seeks permission to study immunological activity of OvaRex in phase II trial

Nov. 11, 1998

AltaRex moves to conduct clinical trial with OvaRex in more advanced ovarian cancer

Nov. 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...